Carregant...
Novel multi-kinase inhibitor, T03 inhibits Taxol-resistant breast cancer
Activation of kinase-associated signaling pathways is one of the leading causes of various malignant phenotypes in breast tumors. Strategies of drug discovery and development have investigated approaches to target the inhibition of protein kinase signaling. In the current study, the anti-tumor activ...
Guardat en:
| Publicat a: | Mol Med Rep |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
D.A. Spandidos
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5783483/ https://ncbi.nlm.nih.gov/pubmed/29207185 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2017.8179 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|